Equities

Orchid Pharma Ltd

ORCHPHARMA:NSI

Orchid Pharma Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)1,392.80
  • Today's Change21.90 / 1.60%
  • Shares traded114.51k
  • 1 Year change+167.15%
  • Beta3.4160
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
REVENUE AND GROSS PROFIT
Total revenue8,1946,6595,596
OPERATING EXPENSES
Cost of revenue total5,6134,5843,136
Selling, general and admin. expenses, total8491,173633
Depreciation/amortization332548870
Unusual expense(income)0(392)0
Other operating expenses, total552--1,296
Total operating expense7,4175,9775,934
Operating income776682(339)
Other, net78(50)(44)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes919552(569)
Provision for income taxes(31)00
Net income after taxes951552(569)
Minority interest------
Net income before extra. Items922531(604)
Total extraordinary items0(68)585
Net income922463(20)
Inc.avail. to common excl. extra. Items922531(604)
Inc.avail. to common incl. extra. Items922463(20)
EPS RECONCILIATION
Basic/primary weighted average shares484141
Basic/primary eps excl. extra items1913(15)
Basic/primary eps incl. extra items1911(0.48)
Dilution adjustment------
Diluted weighted average shares484141
Diluted eps excl. extra items1913(15)
Diluted eps incl. extra items1911(0.48)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock00--
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental8.90146186
SUPPLEMENTAL INCOME
Depreciation, supplemental321548870
Total special items1.88(400)0.00
NORMALISED INCOME
Normalized income before taxes921153(569)
Effect of special items on income taxes0.6600
Income tax excluding impact of special items(31)00
Normalized income after tax952153(569)
Normalized income avail. to common923131(604)
Basic normalized EPS193.21(15)
Diluted normalized EPS193.21(15)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.